MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 140.4 SAR | +0.43% |
|
-3.17% | 0.00% |
| 05-19 | Avalon Pharma Swings to Profit in Q1; Revenue Down | MT |
| 05-06 | Avalon Pharma Secures Regulatory Nod for Second Production Facility in Saudi Arabia | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 148.00 | 164.43 | 162.12 |
| Spread/Res. | -5.14% | -14.61% | -13.40% |
| Spread/Supp. | +3.95% | +12.77% | +7.22% |
| Support | 135.06 | 124.50 | 130.95 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 4016 Stock
- Charts Middle East Pharmaceutical Industries Company
